PRRUF
Price
$0.20
Change
+$0.02 (+11.11%)
Updated
Nov 12 closing price
PVCT
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Dec 17 closing price
Ad is loading...

PRRUF vs PVCT

Header iconPRRUF vs PVCT Comparison
Open Charts PRRUF vs PVCTBanner chart's image
Immutep
Price$0.20
Change+$0.02 (+11.11%)
Volume$1K
CapitalizationN/A
Provectus Biopharmaceuticals
Price$0.13
Change-$0.00 (-0.00%)
Volume$235.67K
CapitalizationN/A
PRRUF vs PVCT Comparison Chart
Loading...
PRRUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRRUF vs. PVCT commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRRUF is a Buy and PVCT is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (PRRUF: $0.20 vs. PVCT: $0.13)
Brand notoriety: PRRUF and PVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRRUF: 81% vs. PVCT: 85%
Market capitalization -- PRRUF: $331.92M vs. PVCT: $54.51M
PRRUF [@Biotechnology] is valued at $331.92M. PVCT’s [@Biotechnology] market capitalization is $54.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRRUF’s FA Score shows that 0 FA rating(s) are green whilePVCT’s FA Score has 1 green FA rating(s).

  • PRRUF’s FA Score: 0 green, 5 red.
  • PVCT’s FA Score: 1 green, 4 red.
According to our system of comparison, PVCT is a better buy in the long-term than PRRUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRRUF’s TA Score shows that 5 TA indicator(s) are bullish while PVCT’s TA Score has 4 bullish TA indicator(s).

  • PRRUF’s TA Score: 5 bullish, 0 bearish.
  • PVCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRRUF is a better buy in the short-term than PVCT.

Price Growth

PRRUF (@Biotechnology) experienced а 0.00% price change this week, while PVCT (@Biotechnology) price change was +9.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

PVCT is expected to report earnings on Nov 18, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRRUF($332M) has a higher market cap than PVCT($54.5M). PVCT YTD gains are higher at: 36.354 vs. PRRUF (-16.687).
PRRUFPVCTPRRUF / PVCT
Capitalization332M54.5M609%
EBITDAN/A-2.78M-
Gain YTD-16.68736.354-46%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A187K-
Total DebtN/A2.8M-
FUNDAMENTALS RATINGS
PRRUF vs PVCT: Fundamental Ratings
PRRUF
PVCT
OUTLOOK RATING
1..100
384
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
9156
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
7540
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PVCT's Valuation (4) in the null industry is significantly better than the same rating for PRRUF (86). This means that PVCT’s stock grew significantly faster than PRRUF’s over the last 12 months.

PVCT's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for PRRUF (91). This means that PVCT’s stock grew somewhat faster than PRRUF’s over the last 12 months.

PRRUF's SMR Rating (97) in the null industry is in the same range as PVCT (100). This means that PRRUF’s stock grew similarly to PVCT’s over the last 12 months.

PVCT's Price Growth Rating (40) in the null industry is somewhat better than the same rating for PRRUF (75). This means that PVCT’s stock grew somewhat faster than PRRUF’s over the last 12 months.

PVCT's P/E Growth Rating (100) in the null industry is in the same range as PRRUF (100). This means that PVCT’s stock grew similarly to PRRUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRRUFPVCT
RSI
ODDS (%)
Bullish Trend 6 days ago
50%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 7 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
PRRUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IAUX0.530.02
+2.95%
i-80 Gold Corp
MU108.600.34
+0.31%
Micron Technology
FTAI130.15-0.49
-0.38%
FTAI Aviation Ltd
RNST36.68-0.72
-1.93%
Renasant Corp
BCAB1.31-0.04
-2.96%
BioAtla

PRRUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRRUF has been loosely correlated with IMMP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PRRUF jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRRUF
1D Price
Change %
PRRUF100%
N/A
IMMP - PRRUF
43%
Loosely correlated
+2.40%
CALC - PRRUF
24%
Poorly correlated
-1.07%
PHGUF - PRRUF
21%
Poorly correlated
+10.58%
PVCT - PRRUF
11%
Poorly correlated
-0.66%
OXBDF - PRRUF
9%
Poorly correlated
N/A
More

PVCT and

Correlation & Price change

A.I.dvisor tells us that PVCT and OMGA have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PVCT and OMGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVCT
1D Price
Change %
PVCT100%
-0.66%
OMGA - PVCT
25%
Poorly correlated
+0.15%
LABFF - PVCT
23%
Poorly correlated
N/A
RVPH - PVCT
20%
Poorly correlated
-39.13%
PPTDF - PVCT
17%
Poorly correlated
N/A
PTIX - PVCT
12%
Poorly correlated
+8.72%
More